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Evidence for the treatment of chronic peptic ulcer
Por many years surgery was considered an importantapproach for the treatment of chronic peptic ulceroThousands of patients were submitted to surgery in
the absence of appropriate controlled trials. If such trials
had been undertaken, the history of the disease could have
been different. Once the link between Helieobaeter pylori
infection and chronic peptic ulcer had been established,
new treatment guidelines based on scientific evidence were
required.
If the interested clinician were to consult the
Cochrane Library, he would find no systematic review
prepared by the" Cochrane Collaboration Group, but two
reviews prepared by outside the collaboration. One of
these, focuses on the effectiveness and the economic
aspects of treatment3, and other on the efficacy of
antibiotictherapy in erradicating Helieobaeter pylori. 2 Both
have been assessed by the Cochrane Collaboration.
Basically the studies are supposed to compare placebo with
omeprazole plus amoxicillin, or these two (dual therapy)
with triple therapy (colloidal bismuth subcitrate,
metronidazole and tetracycline) or quadruple therapy
(omeprazole, colloidal bismuth subcitrate, tetracycline
hydrochloride and metronidazole).
As can be seen, we have tnany agents to be compared
two by two, three by three, four by four, or even to use
them alI. Obviously, when the number of agents increases,
the chances of adverse effects and cost increases. Hence
there are many questions that need to be answered by
appropriate research. If we look at the Cochrane Library
database, we find 157 references on this subject. While it
is good news that there is so much information, the question
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remain of what to do in practice? Two recent trials have
been published that may help to adress this questiono
Boer e col.', in "Quadruple therapy erradicated H.
pylori-associated peptic ulcer disease better than dual
therapy", compared quadruple therapy (n = 40) with dual
therapy (n = 36). Quadruple therapy included omeprazole
- 20 mg twice daily on days 1 to 1O~ colloidal bistnuth
subcitrate, 120 mg, 4 times/d, on days 4 to 1O~ tetracycline
hydrocloride, 500 mg, 4 times/d, on day 4 to 1O~ and
metronidazole 500 mg, 3 times/d, on days 4 to 10. Dual
therapy included omeprazole, 20 mg twice daily, on days
1 to 14 and amoxicillin, 1000 mh twice daily, on daysl to
14. The studied patients where who had chronic peptic
ulcer disease and endoscopically proved Helieobaeter
Pylori infections. The effects were biopsy confinneel.
Quadruple therapy led to a higher cure rate than did
dual therapy 93% vs 56%, P < 0,001. The rate of adverse
effects was higher in the group that received quadruple
therapy than dual therapy group.
Thijs e col.5compared triple therapy, colIoidal bislnuth
subcitrate, 120 mg, ~ times/d, lnetronidazole 250 lng, 4
times/d, and tetracycline 250 mg, 4 tilnes/d, with dual
therapy, omeprazole 40 mg twice daily and atnoxicilIin 1000.
mg twice daily. Both regimens were taken for 14 days. Triple
therapy led to a higher rate of cure than dual therapy (95%
vs 70%, P< 0,001). Again side effects were more frequently
associated with triple than with dual therapy.
Although more larger trials are needed, the reader
can already make a therapeutic decision, keeping in minei
that the fewer drugs used increases compliance and reduces
side effects.
Besides the information in the Cochrane Library the
reader can also refer to the commentary on the paper by
Schoenfeld and Butler 4, and will have more evidence to
guide his pratice.
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